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Abstract
Background: During and shortly after birth, newborn infants are colonized with enterococci. This study analyzes
predictors for early enterococcal colonization of infants in a neonatal intensive care unit and describes risk factors
associated with multidrugresistant enterococci colonization and its seasonal patterns.
Methods: Over a 12-month period, we performed a prospective epidemiological study in 274 infants admitted
to a neonatal intensive care unit. On the first day of life, we compared infants with enterococcal isolates detected
in meconium or body cultures to those without. We then tested the association of enterococcal colonization
with peripartal predictors/risk factors by using bivariate and multivariate statistical methods.
Results: Twenty-three percent of the infants were colonized with enterococci. The three most common
enterococcal species were E. faecium (48% of isolates), E. casseliflavus (25%) and E. faecalis (13%). Fifty-seven
percent of the enterococci found were resistant to three of five antibiotic classes, but no vancomycin-resistant
isolates were observed. During winter/spring months, the number of enterococci and multidrug-resistant
enterococci were higher than in summer/fall months (p = 0.002 and p < 0.0001, respectively). With respect to
enterococcal colonization on the first day of life, predictors were prematurity (p = 0.043) and low birth weight
(p = 0.011). With respect to colonization with multidrug-resistant enterococci, risk factors were prematurity (p
= 0.0006), low birth weight (p < 0.0001) and prepartal antibiotic treatment (p = 0.019). Using logistic regression,
we determined that gestational age was the only parameter significantly correlated with multidrug-resistant
enterococci colonization. No infection with enterococci or multidrugresistant enterococci in the infants was
detected. The outcome of infants with and without enterococcal colonization was the same with respect to death,
necrotizing enterocolitis, intracerebral hemorrhage and bronchopulmonary dysplasia.
Conclusion: In neonatal intensive care units, an infant's susceptibility to early colonization with enterococci in
general, and his or her risk for colonization with multidrug-resistant enterococci in particular, is increased in
preterm newborns, especially during the winter/spring months. The prepartal use of antibiotics with no known
activity against enterococci appears to increase the risk for colonization with multidrug-resistant enterococci.
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Background
Although the fetal gastrointestinal tract is considered to be
sterile [1-3], colonization of the newborn with microor-
ganisms begins during delivery or within minutes after
birth [2,4]. Colonizing microorganisms originate from
the vaginal and gastrointestinal flora of the mother, oral
ingestion of breast milk and formula milk, or from envi-
ronmental sources [1-4]. Among the first microorganisms
detected in the stool of infants, enterococci are commonly
found on the first day of life [1,4]. While enterococci con-
stitute part of the normal intestinal flora of humans (up
to 108 cfu/g stool [5,6]), in smaller numbers, the bacteria
are also detectable in the human genital tract and oral cav-
ity. Enterococci are considered facultative pathogens and
cause a variety of infections, including urinary tract, intra-
abdominal, pelvic, and soft tissue infections, bacteremia
and endocarditis [7]. In preterm infants and other
immuno-compromised patients, infections with entero-
cocci can be life-threatening [8].
Several factors are known to influence the composition of
the microbial flora in infants during and after birth
[1,2,4]. Preterm infants and infants delivered via Cesarean
section display a delayed intestinal colonization with a
smaller species variability and a higher rate of potentially
pathogenic microorganisms [1,3,4,9]. Antibiotic treat-
ment both decreases the amount of anaerobic bacteria
and increases the number of enterobacteriaceae in an
infant's stool [1,4].
In our neonatal intensive care unit, meconium and body
cultures are routinely cultured for surveillance purposes.
In recent years, we noticed an increase in enterococci –
especially aminoglycoside-resistant enterococci – in the
meconium of preterm infants admitted to the neonatal
intensive care unit shortly after birth. In a retrospective
analysis, all enterococci isolated from the meconium over
a 12-month period were characterized.
Strikingly, the colonization of preterm infants with ente-
rococci and aminoglycosideresistant enterococci was
more prevalent during the winter months than during
summer months (unpublished observation). Such an
association is well-established for the bacterial coloniza-
tion of the respiratory tract [10], but has not been known
for colonization of infants with enterococci. From the ret-
rospective study, we developed the following two hypoth-
eses: (1) that there is a seasonal influence on the
enterococcal colonization of newborn infants in neonatal
intensive care units shortly after birth, and (2) that there
is a higher risk for the colonization of preterm infants
with drug-resistant enterococci. Supporting these hypoth-
eses are two key factors: the generally higher rate of anti-
biotic use with no known activity against enterococci
during the winter/spring season, and the specifically
higher rate of antibiotic use by mothers of preterm infants
as compared to mothers of term infants.
To confirm our two hypotheses, we conducted a prospec-
tive epidemiological study. Over a 12-month period, we
monitored colonization of infants with and without ente-
rococci in the meconium and other body cultures shortly
after birth and we simultaneously tracked potential risk
factors for the acquisition of multidrug-resistant entero-
cocci. Understanding the predictors for newborn infants'
early colonization with enterococci is a prerequisite to
interpreting potential risk factors associated with multid-
rug-resistant enterococcal colonization. Colonization
with a pathogen that has multidrug resistance poses a risk
for the development of an infection [11], which is likely
to be difficult to treat with standard antibiotic therapy.
Methods
Setting
Freiburg University Medical Center is a 1,800-bed, tertiary
care facility in southwestern Germany. The Department of
Gynecology and Obstetrics houses an 8-bed neonatal
intensive care unit. Approximately 350 patients are admit-
ted to this unit annually.
Study design
All infants born at the Freiburg University Medical Center
between March 1, 2003 and February 28, 2004 and admit-
ted to the neonatal intensive care unit on their first day of
life were enrolled in our prospective study. Infants born
outside the Freiburg University Medical Center and trans-
ferred to the neonatal intensive care unit on their first day
of life were excluded. Upon admission to the intensive
care unit, specimens were taken from the ear, pharynx and
gastric content, and subsequently cultured. The first meco-
nium was also cultured. Clinical data were prospectively
collected from the infant (i.e., gestational age, birth
weight, sex, symptoms and signs of neonatal infection,
bacteremia, antibiotic treatment, symptoms and signs of
necrotizing enterocolitis, death) as well as from the
mother (i.e., prepartal hospitalization, prepartal antibi-
otic treatment, premature rupture of membranes, recto-
vaginal colonization with enterococci before delivery,
mode of delivery). At our hospital, recto-vaginal swabs are
routinely taken from pregnant women between week 35
and 37 of their pregnancies in order to screen for coloni-
zation with S. agalactiae. Prepartum refers to the period
immediately preceding delivery of an infant. The study
was approved by the Institutional Review Board of the
Freiburg University Hospital. Informed consent was
obtained from the infant's caretaker.
Microbiological methods
Meconium and body cultures were processed at the micro-
biology laboratory of the Center of Pediatrics and Adoles-BMC Infectious Diseases 2007, 7:107 http://www.biomedcentral.com/1471-2334/7/107
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cent Medicine Freiburg according to standard methods on
solid horse-blood and chocolate agar [12]. After identify-
ing an Enterococcus isolate, an API Strep kit was used to
determine the enterococcal species. E. casseliflavus species
was further differentiated from E. faecalis/E. faecium spe-
cies using Methyl-a-D-glucopyranosid- and Sulphide-
Indole-Motility agar.
Antibiotic resistance was determined using the Kirby-
Bauer disc diffusion test. Five different classes of antibiot-
ics were tested (aminopenicillins, carbapenems,
aminoglycosides, sulfonamides/folinic acid antagonists
and vancomycin). Minimum inhibitory concentrations to
aminoglycosides were determined using the E-test [13].
Multidrug resistance was defined by resistance of an ente-
rococcal isolate against three of the five antibiotic classes.
Statistical analysis
For statistical analysis, Microsoft Excel and the software
programs GraphPad Prism V.3 and SPSS 14.0 were used.
Results were expressed either as a mean +/- SD, or as a per-
centage of the total number of isolates or patients. For
continuous variables, median values were compared
using two sample t-tests for independent variables (i.e.,
Mann- Whitney test). Differences in proportions were
compared using either a Chi-square test or Fisher's exact
test, as deemed appropriate. All statistical tests were per-
formed twotailed and considered significant if the p value
was <0.05. For multivariate analysis, logistic regression
was used.
Results
Study population and patient characteristics
During the study period, 297 infants were admitted to the
neonatal intensive care unit on their first days of life.
Twenty-three infants were excluded from the analysis
either because they were born at an outside hospital (n =
16) or because no meconium was cultured (n = 7). Two
hundred seventy-four infant/mother pairs were enrolled
in this study; 144 infants were male and 130 female. The
mean birth weight of the infants was 2.420 g (range 380
to 4.910 g) and the mean gestational age was 35 weeks
(range 23 to 44 weeks). One hundred fifty-seven infants
were born prematurely, (i.e., before 37 weeks of gesta-
tion), and 63 infants were born before 32 weeks of gesta-
tion. The study cohort of 274 infants, stratified by three
gestational age groups, (i.e., ≥ 37 weeks of gestation, 32 to
36 weeks of gestation and < 32 weeks of gestation), is
summarized in Table 1.
Microbiological features
In 63 cases (i.e., 23%), enterococci were isolated from
either body cultures or from the first meconium. Coloni-
zation rates differed according to the three gestational age
groups (Table 2). The group with the highest colonization
rate was infants < 32 weeks of gestation (i.e., 33%). Of the
63 colonized infants, 53 were isolated from meconium
and 10 from body cultures. Differentiation at the species
level showed 30 (48% of all enterococcal isolates) E. fae-
cium, 16 (31%) E. casseliflavus, eight (12%) E. faecalis, two
(3%) E. durans, and seven (11%) undifferentiated entero-
Table 1: Clinical and peripartal features of infants studied, stratified by gestational age.
Gestational 
age
nM e d i a n  
(weeks)
Range 
(weeks)
Cesarean 
section
Prepartal 
hospitalizati
on ≥ 3 days
Prepartal 
antibiotics ≥ 
1 day
PROMa ≥ 24 
hours
Maternal 
rectovaginal 
colonization 
with 
enterococci
≥ 37 weeks of 
gestation
117 39 37–44 62 (53.0%) 4 (3.4%) 5 (4.2%) 2 (1.7%) 33 (28.2%)
32–36 weeks 
of gestation
94 34 32–36 60 (63.8%) 22 (23.4%) 22 (23.4%) 5 (5.3%) 16 (17.0%)
< 32 weeks of 
gestation
63 28 23–31 52 (82.5%) 23 (36.5%) 27 (42.9%) 10 (15.9%) 4 (6.3%)
aPROM indicates premature rupture of membranes
Table 2: Colonization rates of infants with enterococci and multidrug-resistant enterococci in meconium and surveillance cultures 
stratified by gestational age.
Gestational age n Colonization with 
enterococci
Colonization with 
multidrug-resistant 
enterococci
% multidrug-resistant 
enterococci
All patients 274 63 (22.9%) 36 (13.1%) 57.1%
≥ 37 weeks of gestation 117 24 (20.5%) 10 (8.5%) 41.7%
32 – 36 weeks of gestation 94 18 (19.1%) 7 (7.4%) 38.9%
< 32 weeks of gestation 63 21 (33.3%) 19 (30.2%) 90.5%BMC Infectious Diseases 2007, 7:107 http://www.biomedcentral.com/1471-2334/7/107
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coccal species (Figure 1). Thirty-six isolates (57% of all
enterococcal isolates) were resistant to three of the five
antibiotic classes tested and were therefore classified as
multidrug-resistant. All of these multidrug-resistant iso-
lates were resistant to aminopenicillins and aminoglyco-
sides. Of the 36 multidrug-resistant enterococci, 35
isolates were resistant to both sulfonamides and carbap-
enems. In addition to the 36 multidrug-resistant isolates,
five other isolates were resistant to aminoglycoside, and
all of them displayed low-level aminoglycoside resistance
(defined as a minimal inhibitory concentration of gen-
tamicin < 512 µg/ml). None of the enterococci was vanco-
mycin-resistant. Twenty-four (80%) of E. faecium, 11
(69%) of E. casseliflavus, and one (13%) E. faecalis isolate
were multidrug-resistant (Figure 1). All multidrug-resist-
ant isolates were detected in meconium.
Seasonal pattern of enterococcal colonization
The 12-month study was divided into two periods: the
winter/spring season from December 1st to May 31st and
the summer/fall season from June 1st to November 30th. A
minimum of one enterococcal isolate and a maximum of
eight enterococcal isolates were detected per month. A
larger number of enterococcal isolates were detected dur-
ing the winter/spring months as compared to summer/fall
months (p = 0.002, Chi-square test, Figure 2). A higher
prevalence of enterococcal isolates in the winter/spring
season was also noted for multidrug-resistant enterococci,
and here with an even higher statistical significance (p <
0.0001, Figure 2).
Predictors for early colonization with enterococci and 
multidrug-resistant enterococci
Different peripartal predictors for colonization with ente-
rococci in infants on their first day of life were analyzed
(Table 3). Infants colonized with enterococci had a lower
mean gestational age than infants not colonized with
enterococci (34 vs. 35 weeks of gestation, p = 0.043, Fig-
ure 3A). A similar association was noted between infants
colonized with multidrug-resistant enterococci (30.5 vs.
35 weeks of gestation, p = 0.0006, Figure 3B). Infants col-
onized with enterococci also had a lower mean birth
weight than infants not colonized with enterococci (2.020
vs. 2.640 g, p = 0.011, Figure 4A).
Colonization with multidrug-resistant enterococci
revealed a similar association (1.535 vs. 2.635 g, p <
0.0001, Figure 4B). A 2 × 2 comparison of gestational age
groups (< 32 weeks vs. ≥ 32 weeks of gestation) and birth
weight groups (< 1.000 g vs. ≥ 1.000 g) confirmed their
Distribution of different enterococcal species detected in meconium or surveillance cultures of infants (white bars) Figure 1
Distribution of different enterococcal species detected in meconium or surveillance cultures of infants (white bars). The black 
bars represent the number of multidrug-resistant enterococci for each enterococcus species.BMC Infectious Diseases 2007, 7:107 http://www.biomedcentral.com/1471-2334/7/107
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association with the enterococcal colonization status
(Table 3). Prepartal hospitalization, delivery mode, pre-
mature rupture of membranes and maternal rectovaginal
colonization with enterococci were not associated with
the infant's colonization with enterococci or multidrug-
resistant enterococci (Table 3). In contrast, however, pre-
partal antibiotic treatment was associated with coloniza-
tion of infants with multidrugresistant enterococci (p =
0.019, Table 3) although not with enterococcal coloniza-
tion (p = 0.146, Table 3). The following antibiotics were
used for mothers of infants subsequently colonized with
enterococci: cefuroxime (n = 17), ampicillin (n = 2),
erythromycin (n = 1), ceftriaxone (n = 1), clindamycin (n
= 1) and an unknown antibiotic (n = 1). Standard route of
antibiotic administration was parenteral injection. Logis-
tic regression determined that gestational age was the only
parameter significantly correlated with colonization with
multidrug-resistant enterococci (Table 4). Further mode-
ling was not deemed appropriate because of the strong
correlation between gestational age and the parameters of
birth weight and prepartal antibiotic treatment.
Outcome
None of the infants colonized with enterococci shortly
after birth developed an infection with enterococci or
enterococcal bacteremia. The rate of infants suffering from
necrotizing enterocolitis (i.e., 4.8% of the infants colo-
nized with enterococci vs. 1.9% of the infants not colo-
nized with enterococci, p = 0.083) was similar in both
groups. Mortality rates during hospitalization also did not
differ between the two groups (i.e., 3.2% vs. 4.3%, p =
1.000). In addition, the rate of infants who developed an
intracerebral hemorrhage or bronchopulmonary dyspla-
sia was similar between colonized and non- colonized
infants (data not shown).
Distribution of isolates of enterococci and multidrug-resistant enterococci (in % of samples taken per month) in meconium and  surveillance cultures from colonized infants stratified by month of the year Figure 2
Distribution of isolates of enterococci and multidrug-resistant enterococci (in % of samples taken per month) in meconium and 
surveillance cultures from colonized infants stratified by month of the year. There is a statistically significant association for a 
higher colonization rate with enterococci (p = 0.002, Chi-square test) and multidrug-resistant enterococci (p < 0.0001, Chi-
square test) during the winter/spring months as compared to summer/fall months.BMC Infectious Diseases 2007, 7:107 http://www.biomedcentral.com/1471-2334/7/107
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Discussion
The results of our study demonstrate for the first time that
newborn infants can be colonized with multidrug-resist-
ant enterococci from the first day of life. We determined a
possible risk factor to be prepartal antibiotic treatment.
Knowledge of the possibility of early colonization with
multidrug-resistant enterococci is particularly important
in cases where such an infant develops an infection and
requires appropriate antibiotic treatment.
Enterococci are among the first bacteria to colonize the
neonatal gastrointestinal tract. They do so within days of
birth [2-4,14]. Although a primary source for the coloniz-
ing bacteria is the oral ingestion of breast milk [15,16],
bacteria can also be derived from the vaginal and gastroin-
testinal flora of the mother during the birth passage [14].
Older medical literature suggests the fetal gastrointestinal
tract to be sterile [1-3]. More recent studies have shown,
however, that infants may be colonized with enterococci
and other gram-positive bacteria without having had
direct contact with the maternal flora during delivery and
before having been fed [14,17,18]. Jimenez at al. detected
enterococci by culture after enrichment in nine of 20 cord
blood samples from infants delivered via Cesarean section
[14]. In experiments with pregnant mice orally fed with a
genetically labeled E. faecium, the same enterococcal
strain was found in the amnion fluid by polymerase chain
reaction (PCR) before the mice gave birth [14]. A poten-
tial explanation for this finding is the transfer of entero-
cocci ingested by dendritic cells from the gastrointestinal
lumen through the gut epithelium into the circulation
[19].
Table 3: Comparison of peripartal risk factors for colonization with enterococci and multidrugresistant enterococci in meconium and 
surveillance cultures of infants. For differences in proportions between two groups, the Fisher's exact test was performed.
1. Gestational age < 32 weeks
(n = 63)
≥ 32 weeks
(n = 211)
Relative risk (95% CI) p
Enteroccous-positive 21 (33.3%) 42 (19.9%) 1.675 (1.076–2.605) 0.0395
aMDR-enterococcus-positive 19 (30.2%) 17 (8.1%) 3.743 (2.073–6.759) <0.0001
2. Birth weight < 2.500 g
(n = 138)
≥ 2.500 g
(n = 136)
Enterococcus-positive 38 (27.5%) 25 (18.4%) 1.498 (0.959–2.340) 0.085
aMDR-enterococcus-positive 25 (18.1%) 11 (8.1%) 2.240 (1.148–4.371) 0.019
< 1.000 g
(n = 27)
≥ 1.000 g
(n = 247)
Enterococcus-positive 11 (40.7%) 52 (21.1%) 1.935 (1.156–3.239) 0.0293
aMDR-enterococcus-positive 11 (40.7%) 25 (10.1%) 4.025 (2.237–7.244) 0.0001
3. Prepartal hospitalization ≥ 3 days
(n = 49)
< 3 days
(n = 224)
Enterococcus-positive 11 (22.4%) 52 (23.2%) 0.967 (0.546–1.714) 1.000
aMDR-enterococcus-positive 7 (14.3%) 29 (12.9%) 1.108 (0.516–2.383) 0.816
4. Prepartal antibiotics ≥ 1 day
(n = 54)
< 1 day
(n = 216)
Enterococcus-positive 16 (29.6%) 42 (19.4%) 1.460 (0.893–2.388) 0.146
aMDR-enterococcus-positive 12 (22.2%) 21 (9.7%) 2.286 (1.201–4.351) 0.019
5. Delivery mode Cesarean section
(n = 174)
Vaginal delivery
(n = 100)
Enterococcus-positive 42 (24.1%) 21 (21.0%) 1.149 (0.724–1.826) 0.655
aMDR-enterococcus-positive 28 (16.1%) 8 (8.0%) 2.011 (0.954–4.243) 0.0641
6. Maternal rectovaginal colonization Enterococcus-positive
(n = 53)
Enterococcus-negative
(n = 47)
Enterococcus-positive 9 (17.0%) 8 (17.0%) 0.998 (0.419–2.374) 1.000
aMDR-enterococcus-positive 1 (1.9%) 2 (2.1%) 0.443 (0.042–4.737) 0.600
7. PROMb ≥ 24 hours
(n = 17)
< 24 hours
(n = 248)
Enterococcus-positive 2 (11.8%) 58 (23.4%) 0.478 (0.128–1.791) 0.376
aMDR-enterococcus-positive 2 (11.8%) 32 (12.9%) 0.912 (0.238–3.488) 1.000
aMDR indicates multidrug-resistant, bPROM premature rupture of membranesBMC Infectious Diseases 2007, 7:107 http://www.biomedcentral.com/1471-2334/7/107
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No study about colonization of infants' gastrointestinal
tracts after birth has systematically differentiated among
different enterococcal species involved in this process
and/or the influence of peripartal antibiotic treatment.
The aforementioned study by Jimenez et al. detected E.
faecium in cord blood of infants after Cesarean section
[14]. By day ten after birth, infants with extremely low
birth weights were colonized more often with E. faecalis
than with E. faecium strains [9]. Our cohort was colonized
primarily with E. faecium (48% of all enterococcal
strains), followed by E. casseliflavus (31%) and then E. fae-
calis (12%, Figure 1).
This distribution pattern appears to contrast with the ente-
rococcal species distribution causing infection in humans.
The most common enterococcal pathogen is E. faecalis,
which is responsible for 80–90% of enterococcal infec-
tion, followed by E. faecium, which is responsible in 5–
10% of cases [20]. Motile enterococci like E. casseliflavus
and E. gallinarum are responsible for ≈1% of all enterococ-
cal infections [20,21]. Immunocompromised patients
have an especially increased risk of contracting infections
with motile enterococci [21], which are part of the normal
human gastrointestinal flora [21]. In contrast to infection
rates, colonization rates of healthy humans with motile
enterococci are reported to be higher (5.7% to 12.1%)
[21]. A possible explanation for the high prevalence of E.
Comparison of gestational age of infants either colonized or not colonized with (A) enterococci and (B) multidrug-resistant  enterococci in meconium or surveillance cultures Figure 3
Comparison of gestational age of infants either colonized or not colonized with (A) enterococci and (B) multidrug-resistant 
enterococci in meconium or surveillance cultures. Boxes extend from the 25th to the 75th percentile, with a line at the median 
(50th percentile) and whiskers show the highest and the lowest gestational ages. The p values refer to the comparison of the 
median values using the Mann Whitney test.BMC Infectious Diseases 2007, 7:107 http://www.biomedcentral.com/1471-2334/7/107
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Comparison of birth weights of infants either colonized or not colonized with (A) enterococci and (B) multidrug-resistant  enterococci in meconium or surveillance cultures Figure 4
Comparison of birth weights of infants either colonized or not colonized with (A) enterococci and (B) multidrug-resistant 
enterococci in meconium or surveillance cultures. Boxes extend from the 25th to the 75th percentile, with a line at the median 
(50th percentile) and whiskers show the highest and the lowest birth weights. The p values refer to the comparison of the 
median values using the Mann Whitney test.
Table 4: Logistic regression of risk factors associated for colonization with enterococci and multidrug-resistant enterococci (inclusion 
model)
Colonization with
Enterococci Multidrug-resistant enterococci
OR (95% CI) P OR (95% CI) P
Gestational age < 32 weeks 2.116 (0.896–4.990) 0.087 5.307 (1.723–16.347) 0.004
Birth weight < 2500 g 1.150 (0.511–2.582) 0.736 0.861 (0.260–2.845) 0.806
Prepartal hospitalization ≥ 3 days 1.665 (0.680–4.078) 0.265 1.878 (0.625–5.638) 0.261
Prepartal antibiotics ≥ 1 day 0.556 (0.234–1.322) 0.184 0.461 (0.160–1.328) 0.151
Cesarian section 1.182 (0.603–2.315) 0.625 1.908 (0.729–4.995) 0.188
PROMa 4.866 (0.928–25.488) 0.061 3.705 (0.653–21.043) 0.139
aPROM indicates premature rupture of membranesBMC Infectious Diseases 2007, 7:107 http://www.biomedcentral.com/1471-2334/7/107
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faecium strains in our cohort is the high rate of multidrug
resistance. This may give E. faecium strains a selective
advantage for colonization, particularly in the presence of
antibiotic treatment. Eighty percent of E. faecium and 69%
of E. casseliflavus isolates in our cohort were resistant to
three of the five antibiotic classes tested, whereas only
12% of E. faecalis strains were multidrug-resistant.
An association between the rate of enterococcal coloniza-
tion and prematurity has been previously reported in the
literature [22]. In a retrospective case-control study, Mie-
dema et al. analyzed risk factors for enterococcal coloniza-
tion in 579 infants in a neonatal intensive care unit [22].
Twenty percent of their infants were colonized with ente-
rococci (without further species differentiation) either
upon admission to the unit or else during their hospitali-
zation. In a multiple regression analysis, prematurity, days
of hospitalization, deep venous line in place, and antibi-
otics other than amoxicillin were independent risk factors
for enterococcal colonization [22]. Miedema's study
cohort did not differentiate between antibiotic-sensitive
and drug-resistant enterococci. In our cohort, both prema-
turity and low birth weight were predictors for early colo-
nization with enterococci (Figure 2 and 3). This
association was independent of maternal antibiotic use
during pregnancy (Table 3). Two other studies have
shown that maternal antibiotic treatment does not have
an influence on the bacterial colonization in infants after
the tenth day of life [9,23]. Using culture methods,
Gewolb et al. investigated the stool flora of 29 extremely
low birth weight infants on day 10, 20 and 30 of life. The
bacterial flora did not differ between infants with or with-
out maternal antibiotic treatment around the time of birth
[9]. Using real-time PCR, Penders et al. studied the bacte-
rial flora in stool of 1032 infants at one month of age. The
colonization pattern they detected was independent from
maternal antibiotic treatment [23]. In our cohort, how-
ever, maternal antibiotic treatment proved to be a risk fac-
tor for infants' colonization with multidrugresistant
enterococci shortly after birth (Table 3). Antibiotics used
in our cohort were primarily cephalosporins (17 of 23
cases with prepartal antibiotic treatment and subsequent
enterococcal colonization in infants). Because of the high
resistance rates of E. coli to aminopenicillins, cepha-
losporins are the antibiotics standardly used by our hospi-
tal for women experiencing preterm labor. By contrast,
only one pregnant woman who was treated with an ami-
nopenicillin gave birth to an infant colonized with ente-
rococci. Enterococci show an intrinsic resistance against
cephalosporins. The use of cephalosporins may therefore
be responsible for the selective advantage of enterococci
in our cohort. It is unclear to us why the results of our
study revealed only an association between the prepartal
use of antibiotics (mainly cephalosporins) and the colo-
nization with multidrug-resistant enterococci, but not
enterococci in general – this being the case despite the fact
that all enterococci are resistant to cephalosporins. The
association between the use of cephalosporins and subse-
quent colonization with ampicillin-resistant enterococci
has been previously reported in a cohort of adult patients
[24]. An explanation for this phenomenon was not pro-
vided by the authors of this study.
The most striking finding of our study is the higher preva-
lence of early colonization with enterococci and multid-
rug-resistant enterococci in the winter/spring months as
compared to summer/fall months (Figure 1). The same
seasonal pattern was observed at our hospital the year
before this prospective study was performed (data not
shown). A similar seasonal pattern has been reported only
in association with colonization with vancomycin-resist-
ant E. faecium (VREF) [25]. Bischoff et al. described the
molecular epidemiology of 413 vancomycin-resistant iso-
lates from a large urban hospital in Richmond, Virginia
(USA), over a five-year period. They noted higher rates of
VREF isolation during the winter/spring months. An
explanation for this finding was not directly presented by
their study. With S. pneumoniae, it is well documented that
the prevalence of pneumococci is higher in winter
[10,26,27]. Another recent study also noted a higher rate
of penicillin-resistant pneumococci in acute otitis media
cases during winter months [28]. The authors speculate
that the association may be explained by the higher rate of
antimicrobial use in the population during winter
because of the frequency of respiratory tract infection at
that time of the year.
The same increased seasonal use of antibiotics in the pop-
ulation may explain the higher rate of multidrug-resistant
enterococci that we detected in our cohort during the win-
ter and spring months. Winter and spring are the periods
with the highest rates of respiratory tract infections – at
least in the northern hemisphere. In Germany, a surveil-
lance system for respiratory tract infections in children has
found that for the season 2003/2004, the rate of respira-
tory tract infections began in early December 2003 and
ended in May 2004 [29]. Outpatient antibiotic use in the
European population, documented on a quarterly rather
than monthly basis, shows a strongly correlated trend: the
highest rates of outpatient antibiotic use in this popula-
tion are to be found in the first and fourth quarter of the
year [30]. Although the combined data from our retro-
spective and prospective studies suggest a strong link
between an increased rate of enterococcal colonization
and the winter/spring period, a causal relationship
between time of the year and an increased rate of antibi-
otic use in the population cannot yet be conclusively
drawn. Further studies will be needed to confirm this con-
nection.BMC Infectious Diseases 2007, 7:107 http://www.biomedcentral.com/1471-2334/7/107
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Conclusion
The current study has demonstrated that colonization of
newborn infants with enterococci and drug-resistant ente-
rococci is increased in preterm infants, and colonization
with a multidrug-resistant strain may occur around or
shortly after birth. Additionally, we have observed that
colonization with multidrug-resistant enterococci tends
to be more prevalent in winter and spring months. This
increased risk is independent both of the mother's length
of prepartal hospitalization and of the mode of delivery.
Prepartal use of antibiotics with no known activity against
enterococci appears to increase the risk of early coloniza-
tion with drug-resistant enterococci, although notably not
with enterococci overall. None of the infants colonized
with enterococci developed an infection with enterococci
or enterococcal bacteremia. In our cohort, early coloniza-
tion of infants with enterococci or drug-resistant entero-
cocci had no influence on the survival of the infants or on
the rates of necrotizing enterocolitis.
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